TABLE 2.
Kit comparison | Kit standard-based difference
|
VQA standard-based difference
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean | Median | SD | P value | No.b | Mean | Median | SD | P value | No.b | |
Monitor vs ES bDNA | 0.38 | 0.37 | 0.28 | <0.001 | 42 | 0.04 | 0.03 | 0.32 | 0.42 | 42 |
Monitor vs NASBA-QT | −0.18 | −0.15 | 0.29 | <0.001 | 45 | 0.02 | 0.03 | 0.39 | 0.76 | 45 |
NASBA-QT vs ES bDNA | 0.57 | 0.56 | 0.39 | <0.001 | 37 | 0.01 | 0.10 | 0.48 | 0.91 | 37 |
Monitor vs ES bDNA (all) | 0.32 | 0.36 | 0.36 | <0.001 | 311 | 0.04 | 0.04 | 0.37 | 0.11 | 293 |
Monitor vs ES bDNA (placebo) | 0.31 | 0.34 | 0.38 | <0.001 | 159 | 0.03 | 0.03 | 0.43 | 0.37 | 152 |
Monitor vs ES bDNA (zidovudine) | 0.32 | 0.37 | 0.33 | <0.001 | 152 | 0.04 | 0.04 | 0.30 | 0.13 | 141 |
The upper section represents the subset of samples used for a three-way comparison, while the lower section is the entire data set obtained with a two-way comparison. The P value is that obtained by testing the null hypothesis that the average difference was zero.
Number of specimens.